Total Payments
$5,709
2024 Payments
$1,249
Companies
15
Transactions
172
Medicare Patients
19,048
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$3,743 (65.6%)
Consulting$1,925 (33.7%)
Education$41.64 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,743 | 168 | 65.6% |
| Consulting Fee | $1,925 | 1 | 33.7% |
| Education | $41.64 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,357 | 30 | $0 (2024) |
| ABBVIE INC. | $1,384 | 64 | $0 (2024) |
| GENZYME CORPORATION | $310.79 | 9 | $0 (2024) |
| Lilly USA, LLC | $305.96 | 11 | $0 (2024) |
| PFIZER INC. | $248.97 | 14 | $0 (2024) |
| Incyte Corporation | $229.94 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $194.43 | 7 | $0 (2024) |
| NuVasive, Inc. | $164.11 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $153.19 | 8 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $137.25 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,249 | 54 | ABBVIE INC. ($324.49) |
| 2023 | $958.85 | 48 | AbbVie Inc. ($387.06) |
| 2022 | $3,108 | 55 | Novartis Pharmaceuticals Corporation ($2,070) |
| 2021 | $246.44 | 11 | AbbVie Inc. ($116.67) |
| 2020 | $125.24 | 3 | Lilly USA, LLC ($125.24) |
| 2018 | $21.16 | 1 | GENZYME CORPORATION ($21.16) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $31.32 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.03 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.04 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.59 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $47.56 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.14 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.32 | General |
| Category: Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 08/27/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.32 | General |
| Category: Dermatology | ||||||
| 08/26/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Immunology | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: Dermatology | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: Dermatology | ||||||
| 07/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 5,796 | 10,409 | $2.1M | $737,911 |
| 2022 | 36 | 5,319 | 9,896 | $1.9M | $645,410 |
| 2021 | 36 | 5,535 | 9,724 | $1.7M | $593,759 |
| 2020 | 15 | 2,398 | 3,390 | $568,338 | $204,770 |
Total Patients
19,048
Total Services
33,419
Medicare Billing
$2.2M
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,193 | 1,723 | $302,766 | $122,975 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 773 | 1,195 | $259,124 | $89,847 | 34.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 315 | 521 | $217,684 | $86,460 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 422 | 634 | $194,283 | $69,259 | 35.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 308 | 465 | $136,189 | $45,572 | 33.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 90 | 100 | $108,788 | $41,851 | 38.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 592 | 827 | $136,653 | $39,691 | 29.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 242 | 355 | $112,947 | $34,117 | 30.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 59 | 65 | $66,438 | $24,568 | 37.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 480 | 3,028 | $51,234 | $20,772 | 40.5% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 131 | 146 | $51,810 | $18,019 | 34.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 31 | 34 | $40,529 | $15,947 | 39.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 103 | 117 | $72,439 | $14,531 | 20.1% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 104 | 116 | $36,999 | $13,004 | 35.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 110 | 118 | $45,817 | $11,595 | 25.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 62 | 90 | $33,667 | $10,457 | 31.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 125 | 130 | $34,869 | $9,299 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $18,814 | $7,230 | 38.4% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 51 | 53 | $19,214 | $7,214 | 37.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 85 | 85 | $22,534 | $6,912 | 30.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 26 | 50 | $11,529 | $4,188 | 36.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 28 | 29 | $20,214 | $4,057 | 20.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 66 | 74 | $10,051 | $3,709 | 36.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2023 | 29 | 30 | $9,476 | $3,705 | 39.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 32 | $10,695 | $3,690 | 34.5% |
About Dr. Michael Wang, M.D
Dr. Michael Wang, M.D is a Internal Medicine healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1053744912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wang, M.D has received a total of $5,709 in payments from pharmaceutical and medical device companies, with $1,249 received in 2024. These payments were reported across 172 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,743).
As a Medicare-enrolled provider, Wang has provided services to 19,048 Medicare beneficiaries, totaling 33,419 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology, Dermatology
- Location Rochester, MN
- Active Since 08/14/2013
- Last Updated 06/10/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053744912
Products in Payments
- COSENTYX (Biological) $2,085
- SKYRIZI (Biological) $846.56
- DUPIXENT (Biological) $407.81
- RINVOQ (Biological) $386.42
- OPZELURA (Drug) $229.94
- COSENTYX (Drug) $226.66
- Sotyktu (Drug) $194.43
- TALTZ (Drug) $180.72
- CIBINQO (Drug) $171.25
- MaXcess (Device) $164.11
- HUMIRA (Biological) $151.18
- REMICADE (Biological) $113.74
- VTAMA (Drug) $98.01
- EUCRISA (Drug) $77.72
- ADBRY (Biological) $41.18
- TREMFYA (Drug) $39.45
- Zoryve (Drug) $22.06
- JEVTANA (Drug) $21.16
- AMELUZ (Drug) $20.86
- AKLIEF (Drug) $18.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rochester
Dr. Ben George, M.d, M.D
Internal Medicine — Payments: $729,795
Internal Medicine $729,795
John Kisiel, M.d, M.D
Internal Medicine — Payments: $550,377
Internal Medicine $550,377
Gregory Poland, M.d, M.D
Internal Medicine — Payments: $532,099
Internal Medicine $532,099
Christopher Ritchlin, Md, MD
Internal Medicine — Payments: $512,889
Internal Medicine $512,889
Scott Feitell, D.o, D.O
Internal Medicine — Payments: $471,187
Internal Medicine $471,187
Prashant Kapoor, Md, MD
Internal Medicine — Payments: $403,295
Internal Medicine $403,295